Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
12.51
+0.22 (1.79%)
Aug 21, 2026, 3:16 PM EDT - Market open
Core Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 519.18 | 526.52 | 523.85 | 509.79 | 489.74 | 470.25 | |
Revenue Growth | 0.35% | 0.51% | 2.76% | 4.09% | 4.14% | -3.49% |
Cost of Revenue | 417.86 | 417.59 | 420.52 | 399.96 | 393.66 | 367.9 |
Gross Profit | 101.32 | 108.93 | 103.33 | 109.83 | 96.08 | 102.36 |
Selling, General & Admin | 45.67 | 44.23 | 38.59 | 38.89 | 37.57 | 43.87 |
Amortization of Goodwill & Intangibles | 0.47 | 0.36 | 0.5 | 0.49 | 0.69 | 0.76 |
Other Operating Expenses | -1.48 | -1.66 | -2.32 | -1.81 | -1.71 | -1.32 |
Operating Expenses | 59.04 | 57.21 | 51.23 | 52.87 | 53.03 | 61.06 |
Operating Income | 42.28 | 51.72 | 52.1 | 56.97 | 43.05 | 41.3 |
Interest Expense | -11 | -10.57 | -12.37 | -13.43 | -11.57 | -9.15 |
Earnings From Equity Investments | -0.71 | -0.65 | 0.24 | 0.39 | 0.29 | 0.06 |
Currency Exchange Gain (Loss) | -0.86 | -0.75 | -1.2 | -0.18 | -0.23 | 0.23 |
EBT Excluding Unusual Items | 29.72 | 39.75 | 38.77 | 43.75 | 31.55 | 32.44 |
Merger & Restructuring Charges | -0.71 | -2.96 | -2.79 | -2.29 | -3.33 | - |
Gain (Loss) on Sale of Assets | 1.81 | 0.81 | 1.78 | 0.2 | 1.07 | 1.44 |
Asset Writedown | 0.07 | - | - | - | - | - |
Other Unusual Items | - | - | - | -0.46 | - | - |
Pretax Income | 36.8 | 45.9 | 46.19 | 41.21 | 29.95 | 36.11 |
Income Tax Expense | 12.1 | 15.51 | 14.03 | 4.18 | 10.3 | 15.89 |
Earnings From Continuing Operations | 24.7 | 30.39 | 32.15 | 37.03 | 19.66 | 20.22 |
Net Income to Company | 24.7 | 30.39 | 32.15 | 37.03 | 19.66 | 20.22 |
Minority Interest in Earnings | -0.34 | -0.72 | -0.75 | -0.35 | -0.21 | -0.49 |
Net Income | 24.35 | 29.67 | 31.4 | 36.68 | 19.45 | 19.73 |
Net Income to Common | 24.35 | 29.67 | 31.4 | 36.68 | 19.45 | 19.73 |
Net Income Growth | -17.81% | -5.51% | -14.38% | 88.53% | -1.39% | - |
Shares Outstanding (Basic) | 46 | 46 | 47 | 47 | 46 | 46 |
Shares Outstanding (Diluted) | 47 | 47 | 48 | 48 | 47 | 47 |
Shares Change | -1.80% | -1.38% | 0.34% | 1.52% | 0.26% | 4.98% |
EPS (Basic) | 0.53 | 0.64 | 0.67 | 0.79 | 0.42 | 0.43 |
EPS (Diluted) | 0.52 | 0.63 | 0.66 | 0.77 | 0.42 | 0.42 |
EPS Growth | -16.07% | -4.54% | -14.29% | 83.40% | -0.04% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 10.88 | 22.44 | 43.36 | 14.21 | 14.74 | 23.04 |
Free Cash Flow Per Share | 0.23 | 0.48 | 0.91 | 0.30 | 0.32 | 0.49 |
Dividend Per Share | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | -85.71% |
Gross Margin | 19.52% | 20.69% | 19.72% | 21.55% | 19.62% | 21.77% |
Operating Margin | 8.14% | 9.82% | 9.95% | 11.17% | 8.79% | 8.78% |
Profit Margin | 4.69% | 5.63% | 5.99% | 7.19% | 3.97% | 4.20% |
Free Cash Flow Margin | 2.10% | 4.26% | 8.28% | 2.79% | 3.01% | 4.90% |
EBITDA | 57.13 | 66.37 | 67.05 | 72.75 | 60.22 | 59.81 |
EBITDA Margin | 11.00% | 12.61% | 12.80% | 14.27% | 12.29% | 12.72% |
D&A For EBITDA | 14.85 | 14.65 | 14.95 | 15.78 | 17.16 | 18.52 |
EBIT | 42.28 | 51.72 | 52.1 | 56.97 | 43.05 | 41.3 |
EBIT Margin | 8.14% | 9.82% | 9.95% | 11.17% | 8.79% | 8.78% |
Effective Tax Rate | 32.89% | 33.78% | 30.39% | 10.15% | 34.37% | 44.01% |
Revenue as Reported | 519.18 | 526.52 | 523.85 | 509.79 | 489.74 | 470.25 |